Announcements Trials
Browse Landscape

Phase

Phase NA 120Phase 2 111Phase 1 52Phase 1/2 32Phase 3 25Phase EARLY_PHASE1 15Phase 4 10Phase 2/3 4

Status

Completed 40Unknown 33Terminated 13Recruiting 12Active not recruiting 9Not yet recruiting 5Withdrawn 4Suspended 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Colorectal Neoplasms 6Carcinoma, Hepatocellular 5Head and Neck Neoplasms 4Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms, Squamous Cell 2Glioblastoma 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Urinary Incontinence 1Tuberous Sclerosis 1Sarcoma 1Recurrent respiratory papillomatosis 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Postoperative Complications 1Papillomavirus Infections 1Papilloma 1Ovarian Neoplasms 1Orgasm 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Myasthenia Gravis 1Melanoma 1Medication Adherence 1

Interventions

taxane 1bavituximab 1Taxes 1Paclitaxel 1Neoadjuvant Therapy 1Motivational Interviewing 1Docetaxel 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Withdrawn × Breast Neoplasms × Clear all
NCT02883361 2024-12-05

MI for AIs

University of Calgary

Phase 2/3 Withdrawn
Breast

Breast Neoplasms, Medication Adherence

NCT00397761 2021-02-17

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Medstar Health Research Institute

Phase 2/3 Withdrawn
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01724242 2017-11-28

Vaginal DHEA for Women After Breast Cancer

Hadassah Medical Organization

Phase 2/3 Withdrawn
Breast

Breast Neoplasms, Orgasm, Urinary Incontinence

NCT02651610 2017-07-11

Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer

Peregrine Pharmaceuticals

Phase 2/3 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡